CD274 and neoplasm: PD-1 expression is high on T cells in the tumor microenvironment, and its primary ligand, PD-L1, is variably expressed on tumor cells and antigen-presenting cells within tumors, providing a potent inhibitory effect within the tumor microenvironment [18].